Langenfeld
Germany
57
2025-09-11
The entities that hold a legal rights for patent applications filed by inventor HAHN Michael:
Michael HAHN from Langenfeld, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
PHARMACEUTICAL DRY POWDER INHALATION FORMULATION
#2 | 2025-05-15DIAZABICYCLIC SUBSTITUTED IMIDAZOPYRIMIDINES AND THEIR USE FOR THE TREATMENT OF BREATHING DISORDERS
#3 | 2025-03-20TREATMENT OF CARDIOPULMONARY DISORDERS
#4 | 2025-03-06A2-ADRENOCEPTOR SUBTYPE C ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA
#5 | 2025-02-20COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A MUSCARINIC RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA
#6 | 2025-02-20COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A P2X3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF SLEEP APNEA
#7 | 2025-02-20COMBINATION OF AN A2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA
#8 | 2025-02-13COMBINATION OF A TASK1/3 CHANNEL BLOCKER WITH A NOREPINEPHRINE REUPTAKE INHIBITOR FOR THE TREATMENT OF SLEEP APNEA
#9 | 2025-02-132,3-DIHYDROBENZO [B][1, 4]DIOXIN-2-YLMETHYL)PIPERAZIN-1-YL DERIVATES FOR THE TREATMENT OF SLEEP APNEA
#10 | 2024-05-09Treatment of cardiopulmonary disorders
#11 | 2024-01-04COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONIST WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA
#12 | 2023-04-13INHIBITORS OF ADRENORECEPTOR ADRAC2
#13 | 2022-08-18SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE
#14 | 2022-07-14COMBINATION OF AN ?2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA
#15 | 2022-07-14COMBINATION OF AN ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS WITH A TASK1/3 CHANNEL BLOCKER FOR THE TREATMENT OF SLEEP APNEA
#16 | 2022-07-14ARYLQUINOZILINE DERIVATIVES AS ALPHA2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA
#17 | 2022-01-20Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
#18 | 2022-01-20?2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA
#19 | 2021-11-04ALPHA-2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA
#20 | 2021-01-28SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE
#21 | 2020-12-10Branched 3-phenylpropionic acid derivatives and their use
#22 | 2020-05-07Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitors
#23 | 2020-04-09Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disorders
#24 | 2020-03-26PHARMACEUTICAL DOSAGE FORMS CONTAINING TASK-1 AND TASK-3 CHANNEL INHIBITORS, AND THE USE OF SAME IN BREATHING DISORDER THERAPY
#25 | 2020-03-19PHARMACEUTICAL DOSAGE FORMS CONTAINING TASK-I AND TASK-3 CHANNEL INHIBITORS, AND THE USE OF SAME IN BREATHING DISORDER THERAPY
#26 | 2019-06-20BRANCHED 3-PHENYLPROPIONIC ACID DERIVATIVES AND THEIR USE
#27 | 2019-02-282-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
#28 | 2018-12-27Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same
#29 | 2018-10-04Branched 3-phenylpropionic acid derivatives and their use
#30 | 2018-06-21THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)
#31 | 2017-09-145-aminotetrahydroquinoline-2-carboxylic acids and their use
#32 | 2016-09-15Branched 3-phenylpropionic acid derivatives and their use
#33 | 2016-06-09SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis
#34 | 2015-06-25Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
#35 | 2015-06-04N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase
#36 | 2015-05-285-aminotetrahydroquinoline-2-carboxylic acids and their use
#37 | 2015-01-22Substituted azabicycles and use thereof
#38 | 2014-10-16Branched 3-phenylpropionic acid derivatives and their use
#39 | 2014-05-22Substituted 3-phenylpropionic acids and the use thereof
#40 | 2014-02-06Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
#41 | 2014-01-305-aminotetrahydroquinoline-2-carboxylic acids and their use
#42 | 2013-08-08Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
#43 | 2013-03-28Branched 3-phenylpropionic acid derivatives and their use
#44 | 2012-02-02Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
#45 | 2011-06-02SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF
#46 | 2011-02-10Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
#47 | 2010-08-05Lactam-substituted dicarboxylic acids and use thereof
#48 | 2010-07-01Substituted dibenzoic acid derivatives and use thereof
#49 | 2010-02-04Dicarboxylic acid derivatives and their use
#50 | 2009-11-26Difluorophenol derivatives and their use
#51 | 2009-11-19Cyclopropylacetic acid derivatives and use thereof
#52 | 2009-09-10Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders
#53 | 2009-08-27Tetrazole derivatives and their use for the treatment of cardiovascular diseases
#54 | 2007-08-02Substituted aminodicarboxylic acid derivatives having pharmaceutical properties
#55 | 2005-12-29Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosis
#56 | 2005-09-06Derivatives of dicarboxylic acid having pharmaceutical properties
#57 | 2005-09-06Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
167651 ⎘